CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis.

CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis. Front Endocrinol (Lausanne). 2024; 15:1359780.

View in: PubMed

subject areas

Blood Glucose
Cholesterol Ester Transfer Proteins
Diabetes Mellitus, Type 2
Drug Therapy, Combination
Female
Humans
Hypoglycemic Agents
Male
Mendelian Randomization Analysis
Middle Aged
Sodium-Glucose Transporter 2

authors with profiles

Michael Davidson